High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.
about
High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancerImpact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).Treating breast cancer with cell-based approaches: an overview.BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.
P2860
High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
High-Dose Chemotherapy With Au ...... gh-Risk Primary Breast Cancer.
@en
type
label
High-Dose Chemotherapy With Au ...... gh-Risk Primary Breast Cancer.
@en
prefLabel
High-Dose Chemotherapy With Au ...... gh-Risk Primary Breast Cancer.
@en
P2093
P2860
P50
P356
P1476
High-Dose Chemotherapy With Au ...... igh-Risk Primary Breast Cancer
@en
P2093
Daniele Generali
European Group for Blood and Marrow Transplantation (EBMT), Solid Tumor Working Party
Francesco Lanza
Giovanni Rosti
Marco Bregni
P2860
P356
10.1093/JNCIMONOGRAPHS/LGV010
P577
2015-05-01T00:00:00Z